InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
25.87
-1.66 (-6.03%)
At close: Jan 22, 2026

InventisBio Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
14,9627,6718,7067,636--
Upgrade
Market Cap Growth
126.77%-11.89%14.01%---
Upgrade
Enterprise Value
13,4496,0716,7285,265--
Upgrade
Last Close Price
25.8713.3015.1413.28--
Upgrade
PS Ratio
82.8845.4546.92---
Upgrade
PB Ratio
8.984.244.363.45--
Upgrade
P/TBV Ratio
8.994.244.363.45--
Upgrade
EV/Sales Ratio
74.5035.9736.27---
Upgrade
Debt / Equity Ratio
0.010.010.010.010.04-
Upgrade
Asset Turnover
0.100.080.08---
Upgrade
Quick Ratio
21.1320.6513.2920.177.3722.52
Upgrade
Current Ratio
21.2820.7813.4120.417.5022.64
Upgrade
Return on Equity (ROE)
-6.84%-12.61%-13.48%-33.34%-42.22%-208.94%
Upgrade
Return on Assets (ROA)
-5.76%-8.60%-9.08%-20.63%-24.42%-115.73%
Upgrade
Return on Capital Employed (ROCE)
-10.00%-15.30%-16.30%-23.20%-51.70%-101.80%
Upgrade
Earnings Yield
-0.78%-3.13%-3.26%-6.33%--
Upgrade
FCF Yield
-0.83%-3.25%-3.61%-6.35%--
Upgrade
Buyback Yield / Dilution
-1.23%-0.26%-12.97%-10.91%0.25%-
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.